Table 1.
N = 195 | |
---|---|
Characteristic | |
Age, mean (SD), years | 52 (21.4) |
Women, n (%) | 132 (67.7) |
Asset index quintiles, n (%) | |
Poorest | 33 (16.9) |
Poorer | 32 (16.4) |
Average | 34 (17.4) |
Rich | 38 (19.5) |
Richest | 34 (12.3) |
Missing | 24 (12.3) |
Highest education level attained, n (%) | |
None | 73 (37.4) |
Primary | 105 (53.9) |
Secondary & Tertiary | 17 (8.7) |
Smoking history, n (%) | |
Never smoked | 153 (78.5) |
Former smoker | 24 (12.3) |
Current smoker | 18 (9.2) |
Alcohol use history, n (%) | |
Never | 19 (9.7) |
Non-hazardous | 172 (88.2) |
Hazardous | 4 (2.1) |
Comorbid diseases | |
Hypertension, n (%) | 56 (28.7) |
Diabetes mellitus, n (%) | 15 (7.7) |
HIV infection, n (%) | 16 (8.2) |
None | 108 (55.4) |
Self-reported poor medication adherence | 115 (59) |
Aetiology of Heart failure | |
Hypertensive heart disease | 42 (21.5) |
Dilated cardiomyopathies | 39 (20.0) |
Ischemic heart disease | 6 (3.1) |
Unknown | 108 (55.4) |
NYHA¥ functional class at enrollment | |
NYHA class I, n (%) | 0 (0) |
NYHA class II, n (%) | 1 (0.5) |
NYHA class III, n (%) | 85 (43.6) |
NYHA class IV, n (%) | 109 (55.9) |
Left ventricular ejection fraction (LVEF) | |
LVEF*, mean (SD) | 41 (12.9) |
Medication during hospital stay*, n (%) | |
Furosemide | 178 (91.3) |
ACEI/ARB∧ | 54 (27.7) |
Digoxin | 45 (23.1) |
Dobutamine | 20 (10.3) |
Blood test | |
Blood urea nitrogen (mg/dL), mean (SD) | 59.6 (65.4) |
Serum Creatinine (mg/dL), mean (SD) | 2.0 (2.7) |
Serum sodium (mmol/L), mean (SD) | 132 (15.8) |
BNP∞(pg/mL), mean (SD) | 2164 (1762) |
CKMB€ (ng/mL), mean (SD) | 4.3 (10.2) |
SD standard deviation, NYHA¥ New York Heart Association, LVEF* Left ventricular Ejection fraction, HIV Human Immunodeficiency virus, ACEI/ARB∧ Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker, BNP∞ Brain Natriuretic Peptide, CKMB€ Creatine-Kinase (MB isomer)
*Most participants took multiple medications thus the percentages of medications add up to more than 100%